THC Pharm GmbH is doing pioneering work in the development of drug therapy approaches for critically ill and multimorbid patients. A clear focus is on the provision of the prescription substances dronabinol and cannabidiol, which belong to the substance class of cannabinoids, for supportive therapy, since the supply of approved finished medicinal products is often problematic, especially for difficult pediatric and palliative ...
THC Pharm GmbH is doing pioneering work in the development of drug therapy approaches for critically ill and multimorbid patients. A clear focus is on the provision of the prescription substances dronabinol and cannabidiol, which belong to the substance class of cannabinoids, for supportive therapy, since the supply of approved finished medicinal products is often problematic, especially for difficult pediatric and palliative patient groups.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.